Target intelligence / Profile preview

L-tyrosine (Tyr)

Target
Tyr
Molecular classification
Amino acid, Proteinogenic amino acid, Phenol derivative, Small molecule
01

Overview

L-tyrosine is a non-essential, proteinogenic amino acid that serves as a critical precursor for several physiologically important molecules, including catecholamine neurotransmitters (dopamine, norepinephrine, and epinephrine), thyroid hormones, and the pigment melanin (PubChem, CID 6057). It is synthesized endogenously from phenylalanine by the enzyme phenylalanine hydroxylase (StatPearls, Tyrosine). In clinical practice, L-tyrosine is primarily relevant in the management of metabolic disorders such as phenylketonuria (PKU), where it becomes an essential amino acid, and tyrosinemia, where its metabolic pathway is disrupted (NORD, Tyrosinemia). While not a therapeutic target in the traditional sense (like a receptor or enzyme), its levels are pharmacologically modulated, and it is used as a dietary supplement to support cognitive function under stress (NIH, Dietary Supplement Fact Sheets). Drugs like nitisinone target the enzymes involved in tyrosine catabolism to prevent the accumulation of toxic metabolites (DrugBank, DB00517). Additionally, L-tyrosine can interact with medications such as MAOIs, potentially leading to hypertensive crises, and may compete with Levodopa for transport into the central nervous system (Mayo Clinic).

Other names
(S)-2-Amino-3-(4-hydroxyphenyl)propanoic acid4-hydroxyphenylalanineL-p-TyrosineY
02

Mechanism of action

L-tyrosine serves as a metabolic substrate for the synthesis of catecholamines, thyroid hormones, and melanin (PubMed, PMID 2736402). It is converted to L-DOPA by tyrosine hydroxylase, which is the rate-limiting step in the production of dopamine, norepinephrine, and epinephrine (Wikipedia, Tyrosine). Pharmacological modulation of tyrosine levels is achieved by inhibiting catabolic enzymes like 4-hydroxyphenylpyruvate dioxygenase (DrugBank, DB00517).

03

Biological functions

Protein synthesisCatecholamine neurotransmitter synthesisThyroid hormone synthesisMelanogenesis
04

Disease associations

Tyrosinemia Type I, II, and IIIPhenylketonuria (PKU)DepressionAlbinismParkinson's disease
05

Safety considerations

Hypertensive crisis when combined with MAOIs (PubChem)Potential to exacerbate melanoma (PubMed)Competition with other large neutral amino acids for blood-brain barrier transport (StatPearls)Interference with Levodopa absorption in Parkinson's disease
06

Interacting drugs

Nitisinone

4 more in the full profile.

07

Biomarkers

Plasma tyrosine concentrationUrinary succinylacetoneUrinary 4-hydroxyphenylpyruvatePlasma phenylalanine-to-tyrosine ratio

Beyond the preview

Go deeper on L-tyrosine (Tyr).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-tyrosine (Tyr).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call